Catalyst Wire Dossier Catalyst Wire Dossier

ABREVA

Docosanol · Haleon US Holdings LLC
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ABREVA, covering 2007-05-23 to 2026-04-14. Get the full timeline:

Most recent: FDA Approved: ABREVA — Supplemental Application (Haleon US Holdings LLC)

See pricing